New approach to treat castration resistant prostate cancer
Links shared publicly online about this topic.
- 740total visits
New approach to treat castration resistant prostate cancer
View full resource at news-medical.net
Tags: Cancer, Prostate Cancer, Prostate, Disease and Condition, Protein, Men's Health, disease
Most Recently Shared on November 9, 2010 at 7:53 am By:
Prostate Cancer: New approach to treat castration resistant prostate cancer: A monoclonal antibody targeting a w... http://bit.ly/cpWRsT
Also Shared By:
Castration-Resistant Prostate Cancer: Mechanisms, Targets, and Treatment
hindawi.com — “Patients with castration-resistant prostate cancer (CRPC), who progress after docetaxel therapy, had until very recently, only a few therapeutic options. Recent advances in this field brought about new perspectives in the treatment of this disease. Molecular, basic, and translational research has given us a better understanding on the mechanisms of CRPC. This great investment has turned into a more rational approach to the development of new drugs. Some of the new treatments are already availabl” View full resource at hindawi.com
Most Recently Shared on March 6, 2012 at 6:38 am By:
Castration-Resistant Prostate Cancer: Mechanisms, Targets, and Treatment: Patients with castration-resistant pro... http://t.co/q3fowhsg
Abiraterone acetate may improve survival for patients with metastatic advanced prostate cancer - - ModernMedicine
modernmedicine.com — “Patients with metastatic castration-resistant prostate cancer treated with the investigational agent abiraterone acetate plus low-dose prednisone/prednisolone showed a significant improvement in overall survival compared to patients treated with prednisone/prednisolone plus placebo, according to a phase 3 study published in the May 26 issue of the New England Journal of Medicine.” View full resource at modernmedicine.com
Most Recently Shared on June 2, 2011 at 7:59 pm By:
Abiraterone acetate may improve survival for patients with metastatic advanced ... http://bit.ly/kbXJJV
Abiraterone Acetate Significantly Improves Overall Survival Of Patients With Post-Chemotherapy Metastatic Castration-Resistant Prostate Cancer
medicalnewstoday.com — “A study published today in The New England Journal of Medicine in patients with metastatic advanced prostate cancer following chemotherapy who were treated with abiraterone acetate plus p” View full resource at medicalnewstoday.com
Most Recently Shared on May 26, 2011 at 1:08 pm By:
john clay mchugh Surgeon, Urologist, Physician, and Doctor
Abiraterone Acetate Significantly Improves Overall Survival Of Patients With Post-Chemotherapy Metastatic Castra... http://bit.ly/m4luLn
Abiraterone Acetate Significantly Improves Overall Survival Of Patients With Post-Chemotherapy Metastatic Castration-Resistant Prostate Cancer
medicalnewstoday.com — “A study published today in The New England Journal of Medicine in patients with metastatic advanced prostate cancer following chemotherapy who were treated with abiraterone acetate plus p” View full resource at medicalnewstoday.com
Most Recently Shared on May 26, 2011 at 12:06 pm By:
Abiraterone Acetate Significantly Improves Overall Survival Of Patients With Post-Chemotherapy Metastatic Castration-R... http://mnt.to/3Wpg
Bavarian Nordic Announces Start Of Randomized Phase 2 Study Comparing PROSTVAC(R) And Chemotherapy Versus Chemotherapy
medicalnewstoday.com — “Bavarian Nordic A/S (OMX: BAVA) announced the initiation of a new multicenter, randomized Phase 2 study of patients with metastatic castration-resistant prostate cancer (mCRPC) treated with PROSTV” View full resource at medicalnewstoday.com
Most Recently Shared on March 1, 2011 at 12:24 pm By:
john clay mchugh Surgeon, Urologist, Physician, and Doctor
Bavarian Nordic Announces Start Of Randomized Phase 2 Study Comparing PROSTVAC(R) And Chemotherapy Versus Chemot... http://bit.ly/gFBRC6
New Drug May Help Men with Hard-To-Treat Prostate Cancer - Renal and Urology News
renalandurologynews.com — “ORLANDO--"An investigational drug called abiraterone acetate may improve the chances of survival among men with metastatic castration-resistant prostate cancer (CRPC) whose disease is progressing after receiving docetaxel-based chemotherapy, according to new findings.” View full resource at renalandurologynews.com
Most Recently Shared on February 20, 2011 at 1:13 pm By:
Renal Urology News Medical Publisher, Health News, Nephrology, and Urology
New Drug May Help Men with Hard-To-Treat Prostate Cancer: ORLANDO—An investigational drug called abiraterone ace... http://bit.ly/eMJM4w
Sipuleucel-T Immunotherapy for Castration-resistant Prostate Cancer. - QualityPoint Technologies
qualitypointtech.net — “This is an important article describing a new treatment paradigm using autologous cellular immunotherapy to treat prostate cancer. Faculty of 1000 Medicine” View full resource at qualitypointtech.net
Most Recently Shared on September 30, 2010 at 1:00 pm By:
Sipuleucel-T Immunotherapy for Castration-resistant Prostate Cancer.: This is an important article describing a ne... http://bit.ly/dfnNlK
New targeted therapy effective in treating advanced prostate cancer
physorg.com — “An experimental drug is showing promise for the treatment of men with an aggressive form of advanced prostate cancer. A new multicenter study has concluded that the targeted therapy MDV3100 is safe and effective for patients with castration-resistant prostate cancer (CRPC), known for its poor prognosis ...” View full resource at physorg.com
Most Recently Shared on April 14, 2010 at 11:24 pm By:
Mona Jauhar Health Professional
New targeted therapy effective in treating advanced prostate cancer: An experimental drug is showing promise for t... http://bit.ly/arSb08
New targeted therapy effective in treating advanced prostate cancer
physorg.com — “An experimental drug is showing promise for the treatment of men with an aggressive form of advanced prostate cancer. A new multicenter study has concluded that the targeted therapy MDV3100 is safe and effective for patients with castration-resistant prostate cancer (CRPC), known for its poor prognosis ...” View full resource at physorg.com
Most Recently Shared on April 14, 2010 at 11:21 pm By:
PhysOrg Health News Health News
New targeted therapy effective in treating advanced prostate cancer http://tw.physorg.com/190490555
Effective prostate cancer treatment discovery
sciencedaily.com — “Biomedical scientists have identified a new way to treat castrate resistant cells in prostate cancer sufferers.” View full resource at sciencedaily.com
Most Recently Shared on March 1, 2010 at 9:22 pm By:
Effective prostate cancer treatment discovery http://bit.ly/aB7u0i
Effective prostate cancer treatment discovery
physorg.com — “Monash University biomedical scientists have identified a new way to treat castrate resistant cells in prostate cancer sufferers - the most common cancer in Australian men.” View full resource at physorg.com
Most Recently Shared on February 26, 2010 at 11:01 am By:
PhysOrg Health News Health News
Effective prostate cancer treatment discovery http://tw.physorg.com/186383904
Effective prostate cancer treatment discovery
eurekalert.org — “Monash University biomedical scientists have identified a new way to treat castrate resistant cells in prostate cancer sufferers -- the most common cancer in Australian men.” View full resource at eurekalert.org
Most Recently Shared on February 25, 2010 at 11:51 pm By:
Effective prostate cancer treatment discovery http://bit.ly/cCpt9s
Counting tumor cells in blood predicts treatment benefit in prostate cancer
eurekalert.org — “Counting the number of tumor cells circulating in the bloodstream of patients with castration-resistant prostate cancer can accurately predict how well they are responding to treatment, new results show. At the ESMO Conference Lugano organized by the European Society for Medical Oncology, researchers showed that changes in the number of circulating tumor cells predicted the outcome after chemotherapy in this hard to treat cancer.” View full resource at eurekalert.org
Most Recently Shared on July 6, 2008 at 8:24 am By:
AAAS Counting tumor cells in blood predicts treatment benefit in prostate cancer http://tinyurl.com/6nnebl
Advertisement
News-Medical.Net
@NewsMedical
New approach to treat castration resistant prostate cancer: A monoclonal antibody targeting a well known cell su... http://bit.ly/cpWRsT
1 year ago...